Antiprotozoal: Drug

Malaria remains the most prevalent, with an estimated 249 million cases in 2022. Other major targets include Chagas disease, leishmaniasis, giardiasis, and trichomoniasis.

Over 60% of prescriptions are issued in lower-middle-income economies, with India and China manufacturing roughly 72% of the global generic supply for key drugs like metronidazole. Common Drugs and Their Applications antiprotozoal drug

Antiprotozoal drugs are a class of medications specifically designed to treat infections caused by protozoa—single-celled eukaryotic organisms. These drugs are critical for managing diseases that primarily affect tropical and subtropical regions, impacting over annually. Market and Clinical Landscape Malaria remains the most prevalent, with an estimated

Compounds such as Metronidazole , Atovaquone, and Benznidazole continue to lead treatment protocols. Malaria remains the most prevalent